4.5 Review

TNF in the liver: targeting a central player in inflammation

Journal

SEMINARS IN IMMUNOPATHOLOGY
Volume 44, Issue 4, Pages 445-459

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00281-022-00910-2

Keywords

TNF signalling; Inflammation; Apoptosis; Viral hepatitis; Non-alcoholic fatty liver disease; Autoimmune hepatitis; Primary sclerosing cholangitis

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [SFB 841, KFO306]

Ask authors/readers for more resources

Tumour necrosis factor-alpha (TNF) is a multifunctional cytokine that plays important roles in immunopathogenesis and liver functions. Targeting TNF signalling through anti-TNF therapies could be a potential treatment for TNF-related diseases.
Tumour necrosis factor-alpha (TNF) is a multifunctional cytokine. First recognized as an endogenous soluble factor that induces necrosis of solid tumours, TNF became increasingly important as pro-inflammatory cytokine being involved in the immunopathogenesis of several autoimmune diseases. In the liver, TNF induces numerous biological responses such as hepatocyte apoptosis and necroptosis, liver inflammation and regeneration, and autoimmunity, but also progression to hepatocellular carcinoma. Considering these multiple functions of TNF in the liver, we propose anti-TNF therapies that specifically target TNF signalling at the level of its specific receptors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available